CN101632640B - 一种美洛昔康脂质体及其药物组合物 - Google Patents
一种美洛昔康脂质体及其药物组合物 Download PDFInfo
- Publication number
- CN101632640B CN101632640B CN2009101478240A CN200910147824A CN101632640B CN 101632640 B CN101632640 B CN 101632640B CN 2009101478240 A CN2009101478240 A CN 2009101478240A CN 200910147824 A CN200910147824 A CN 200910147824A CN 101632640 B CN101632640 B CN 101632640B
- Authority
- CN
- China
- Prior art keywords
- meloxicam
- liposome
- pharmaceutical composition
- buffer
- lecithin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101478240A CN101632640B (zh) | 2009-06-15 | 2009-06-15 | 一种美洛昔康脂质体及其药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101478240A CN101632640B (zh) | 2009-06-15 | 2009-06-15 | 一种美洛昔康脂质体及其药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101632640A CN101632640A (zh) | 2010-01-27 |
CN101632640B true CN101632640B (zh) | 2011-09-28 |
Family
ID=41592086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009101478240A Expired - Fee Related CN101632640B (zh) | 2009-06-15 | 2009-06-15 | 一种美洛昔康脂质体及其药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101632640B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101797230B (zh) * | 2010-04-19 | 2012-08-01 | 王明 | 一种氯沙坦钾氢氯噻嗪药物组合物脂质体固体制剂 |
CN105055316A (zh) * | 2015-08-12 | 2015-11-18 | 邓学峰 | 一种奥美拉唑的化合物 |
CN105056241A (zh) * | 2015-08-12 | 2015-11-18 | 邓学峰 | 一种泮托拉唑的化合物 |
CN106896162B (zh) * | 2015-12-17 | 2019-10-18 | 瑞普(天津)生物药业有限公司 | 一种检测美洛昔康片中杂质的hplc方法 |
EP3541815A4 (en) * | 2016-11-18 | 2020-07-15 | Pacira Pharmaceuticals, Inc. | ZINC MELXICAM COMPLEX MICROPARTICLE MULTIVESICULAR LIPOSOME FORMULATIONS AND METHODS OF MAKING THE SAME |
CN109806228A (zh) * | 2017-11-21 | 2019-05-28 | 北京泰德制药股份有限公司 | 一种含有美洛昔康脂质体的溶液 |
CN113616597A (zh) * | 2021-08-02 | 2021-11-09 | 上海交通大学 | 一种美洛昔康的注射剂及其制备方法和用途 |
CN114504553B (zh) * | 2022-02-28 | 2023-06-06 | 沈阳信达泰康医药科技有限公司 | 一种含有卵磷脂的美洛昔康的纳米分散体系 |
-
2009
- 2009-06-15 CN CN2009101478240A patent/CN101632640B/zh not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
冯淑华等.美洛昔康脂质体凝胶剂的研制与质量评价.《中国现代应用药学杂志》.2008,第25卷(第2期),124. * |
许时婴等.丹参酮前体脂质体球形粉末制剂及其制备方法.《微胶囊技术原理与应用》.2006,120页. * |
Also Published As
Publication number | Publication date |
---|---|
CN101632640A (zh) | 2010-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101632640B (zh) | 一种美洛昔康脂质体及其药物组合物 | |
JP2009544617A5 (zh) | ||
CN100490807C (zh) | 一种头孢呋辛酯脂质体、其制备方法及含有它的药物组合物 | |
CN101716153B (zh) | 一种奥硝唑脂微球固体制剂 | |
CN102166208B (zh) | 赖诺普利氢氯噻嗪药物组合物脂质体固体制剂 | |
CN101637451B (zh) | 一种氯诺昔康脂质体药物组合物及其固体制剂 | |
CN101642433B (zh) | 一种尼美舒利脂质体固体制剂及其药物组合物的制备方法 | |
CN101703470B (zh) | 一种氟康唑脂质体固体制剂及其新应用 | |
CN102028658B (zh) | 瑞舒伐他汀钙脂质体固体制剂 | |
CN102697765B (zh) | 盐酸雷尼替丁枸橼酸铋钾药物组合物固体脂质纳米粒制剂 | |
CN102078300B (zh) | 托拉塞米脂质体固体制剂 | |
CN102138899B (zh) | 阿齐沙坦酯脂质体固体制剂 | |
CN102091044B (zh) | 一种头孢呋辛酯脂微球固体制剂 | |
CN102327226B (zh) | 一种头孢丙烯脂质纳米粒固体制剂 | |
CN102327217B (zh) | 一种头孢泊肟酯脂质体固体制剂 | |
CN102716098A (zh) | 一种头孢妥仑匹酯脂质体固体制剂 | |
CN102085187A (zh) | 孟鲁司特钠脂质体固体制剂 | |
CN102327222A (zh) | 一种盐酸托烷司琼脂质体注射剂 | |
CN102579345B (zh) | 厄贝沙坦脂质体固体制剂 | |
CN102327218B (zh) | 一种头孢地尼脂质体固体制剂 | |
CN102091039B (zh) | 一种头孢特仑新戊酯脂质体固体制剂 | |
CN105287429A (zh) | 一种鸦胆子油固体自乳化胶囊的制备方法 | |
CN103040749A (zh) | 盐酸沙格雷酯脂质体固体制剂 | |
CN102366409B (zh) | 一种尼扎替丁脂质体固体制剂 | |
CN103462914B (zh) | 一种头孢克肟片剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HAINAN YONGTIAN PHARMACEUTICAL INSTITUTE CO., LTD. Free format text: FORMER OWNER: TAO LINGGANG Effective date: 20130725 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 570125 HAIKOU, HAINAN PROVINCE TO: 570216 HAIKOU, HAINAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130725 Address after: 570216 C03, Haikou Free Trade Zone, Hainan, China Patentee after: Hainan Yongtian Pharmaceutical Institute Co., Ltd. Address before: The new business building No. 48 570125 Hainan city of Haikou province China World Trade Center Road, room 2601 Patentee before: Tao Linggang |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110928 Termination date: 20160615 |